DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ogiwara K, Nogami K, Matsumoto T, Shima M.
Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor.
Int J Hematol 2014;
99 (05) 577-587
We do not assume any responsibility for the contents of the web pages of other providers.